GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL granted 55,867 inducement RSUs to 59 new non-executive employees, vesting over about four years starting August 31, 2027.
Rhea-AI Summary
GRAIL (GRAL) granted employment inducement restricted stock units to new non-executive employees under Nasdaq Listing Rule 5635(c)(4), as of September 3, 2026.
The awards cover an aggregate of 55,867 RSUs tied to GRAIL common stock, issued to 59 recently hired non-executive employees as a material inducement to join the company. The RSUs were granted under GRAIL's Inducement Equity Incentive Plan and its standard restricted stock award agreement. The plan is used only for individuals who were not previously employed by GRAIL, or who return after a bona fide break in service. The RSUs vest over approximately four years, with 25% vesting on August 31, 2027 and the remaining portions vesting on each one-year anniversary thereafter, subject to continued employment with GRAIL or its affiliates.
Positive
- 55,867 inducement RSUs help attract and retain 59 new non-executive hires
- Four-year vesting schedule with 25% cliff vesting in 2027 supports employee retention
Negative
- Equity inducement awards covering 55,867 shares create incremental share-based dilution over the vesting period
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 31 | Healthcare conference presentation | Neutral | +0.6% | Management presentation scheduled for Morgan Stanley's healthcare conference |
| Aug 07 | FDA advisory meeting | Neutral | +9.6% | FDA advisory committee scheduled to review Galleri's PMA application |
| Aug 05 | Second-quarter earnings | Neutral | -14.5% | Revenue growth and ongoing losses were reported for the second quarter |
| Jul 30 | Growth conference presentation | Neutral | -3.6% | Management presentation scheduled for Canaccord Genuity's growth conference |
| Jul 29 | Earnings release scheduling | Neutral | +12.1% | Second-quarter financial results release and webcast were scheduled |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior news reactions were mixed across conference, regulatory-scheduling, and earnings-related announcements, with no consistent directional response.
Key Terms
restricted stock units financial
nasdaq listing rule 5635(c)(4) regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of GRAIL, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with GRAIL, pursuant to Nasdaq Listing Rule 5635(c)(4).
The RSUs vest over an approximately four year period, with
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Sunnyvale, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302869327.html
SOURCE GRAIL, Inc.